SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 787.37+3.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (1886)4/1/2016 10:57:12 AM
From: The Ox  Read Replies (1) of 3559
 
REGN is one of the leaders in the industry, so if their stock is weak, it makes sense that many of the smaller companies would not have strong price charts.

If REGN can start to show strength, it's very possible this will help put more of a floor under the entire sector.

As to valuations and which specific drug or testing program is going to be seen as "worth more" down the road.... I'll leave that to more knowledgeable folks. I'm cautious to add anything more than my layman's 2 cents worth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News